Results 251 to 260 of about 659,948 (302)

Inhibition of de novo ceramide synthesis mitigates alpha-synuclein pathology in a Parkinson's disease mouse model. [PDF]

NPJ Parkinsons Dis
Lee E, Park MY, Park M, Kim NY, Wei S, Hwang N, Ryu D, Ryu H, Park D, Lee G, Oh CM.   +10 more
europepmc   +1 more source

Enteric glia, neuropeptides, and Parkinson's: impacts of calcitonin gene-related peptide on gut alpha synuclein. [PDF]

Am J Physiol Gastrointest Liver Physiol
Templeton HN, Lanser TB, Tobet SA, Schwerdtfeger LA.   +3 more
europepmc   +1 more source

Alpha-synuclein absence affected mitochondrial fusion and functions

, 2018
Pizzi M, Valerio A, Longhena F, Faustini G, Bono F, Ziviani E, Bellucci A.   +6 more
core  

Cholesterol modulates vesicle clustering mediated by alpha-synuclein in a nonlinear fashion. [PDF]

Biophys Rep
Tyoe O, Aryal C, Diao J.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Interaction of alpha-synuclein with lipids

2022
Alpha-synuclein (α-syn) is a natively unfolded protein that is abundantly expressed in the central nervous system. Although it has been shown to be involved in neurotransmission and cognition, its exact functions remain elusive. The misfolding of this protein into β-sheet-rich amyloid structures and subsequent aggregation has been associated with ...
Neha, Kachappilly, Jyotirmay, Srivastava, Bani Prasad, Swain, Poonam, Thakur   +3 more
openaire   +2 more sources

Prion Properties of Alpha-Synuclein

Molecular Biology, 2019
The prion properties of alpha-synuclein, a key aggregating protein involved in the pathogenesis of so-called synucleinopathies, including Parkinson's disease (PD), dementia with Lewy bodies, multiple system atrophy, and its various conformers are discussed.
A L, Schwarzman, K A, Senkevich, A K, Emelyanov, S N, Pchelina   +3 more
openaire   +2 more sources